bacopaside-i and Blepharoptosis

In the present study, the antidepressant-like effect of bacopaside I, a saponin compound present in the Bacopa monniera plant, was evaluated by behavioral and neurochemical methods. Bacopaside I (50, 15 and 5 mg/kg) was given to mice via oral gavage for 7 successive days. The treatment significantly decreased the immobility time in mouse models of despair tests, but it did not influence locomotor activity. Neurochemical assays suggested that treatment by bacopaside I (50, 15 and 5 mg/kg) improved brain antioxidant activity to varying degrees after the behavioral despair test. Bacopaside I (15 and 5 mg/kg) significantly reversed reserpine-induced depressive-like behaviors, including low temperature and ptosis. Conversely, bacopaside I did not affect either brain MAO-A or MAO-B activity after the behavioral despair test in mice. Additionally, 5-hydroxytryptophan (a precursor of 5-serotonin) was not involved in the antidepressant-like effect of bacopaside I. These findings indicated that the antidepressant-like effect of bacopaside I might be related to both antioxidant activation and noradrenergic activation, although the exact mechanism remains to be further elucidated.

Topics: Administration, Oral; Animals; Antidepressive Agents; Blepharoptosis; Catalase; Dose-Response Relationship, Drug; Glutathione Peroxidase; Hypothermia; Locomotion; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Monoamine Oxidase; Norepinephrine; Oxidative Stress; Reserpine; Saponins; Serotonin; Stress, Physiological; Superoxide Dismutase; Swimming; Triterpenes